Stryker Corporation

Stryker completes acquisition of ZuriMED to enhance its shoulder offering

Stryker completed its acquisition of ZuriMED, a privately held developer of the FiberLocker System, adding the technology to its Sports Medicine portfolio. The FiberLocker System is a commercialized rotator cuff augmentation technology designed to increase the biomechanical strength of repair. No deal terms were disclosed; the acquisition is a portfolio-expanding tuck-in for Stryker's shoulder care business.

•6d ago

Stryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal

Stryker received FDA 510(k) clearance for Sonopet 3, the latest version of its ultrasonic bone and soft tissue removal platform. The platform adds enhanced power, precision, and new technologies including RISE and Pulse Control, developed with input from hundreds of surgeons. First clinical cases begin in October with a full commercial launch expected later this fall; the clearance modestly supports the Neurosurgical franchise within Stryker's broad MedSurg and Neurotechnology portfolio.

•18d ago

Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery

Stryker announced a strategic alliance with CMR Surgical anchored by an approximately $400 million (£300 million) preferred equity investment in the privately held robotics maker. The deal grants Stryker an exclusive option to acquire 100% of CMR Surgical's outstanding equity and makes Stryker the exclusive U.S. sales agent for the Versius surgical robot portfolio. Management framed the move as a disciplined entry into soft-tissue robotics, a high-growth adjacency to Stryker's endoscopy and visualization businesses; the investment remains subject to regulatory approvals and customary closing conditions.

•20d ago

Stryker Launches Mako 4 SmartRobotics™ in India, Advancing the Next Generation of Robotic-Assisted Joint Replacement

Stryker launched Mako 4 SmartRobotics in India, the fourth generation of its robotic-arm assisted joint replacement platform, spanning total knee, partial knee and total hip applications. The system pairs 3D CT-based planning with AccuStop haptic guidance for patient-specific procedure planning and real-time intraoperative control. The global Mako platform has supported more than 2.5 million procedures across 47 countries, and the India launch aims to expand access as demand for advanced orthopaedic care grows.

•28d ago

Stryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™

Stryker is showcasing two new Foot & Ankle technologies at the 2026 American Orthopaedic Foot & Ankle Society Annual Meeting in Seattle: Prophecy Surgical Planning now available for the Incompass Total Ankle System, and the new Hoffmann LRF smartHEX platform. Prophecy has processed more than 100,000 ankle cases over 14 years and now brings patient-specific 3D planning, plus both resect-through and pin-through fixation options, to Stryker's newest total ankle system. Hoffmann LRF smartHEX expands the limb reconstruction portfolio with new rings, struts and frame components, a mobile app, and updated planning software aimed at complex deformity correction and connected care. The release contains no financial figures or guidance and reads as an incremental portfolio extension rather than a market-moving catalyst.

•1mo ago

Stryker introduces first of its kind FDA-authorized surgical application for Apple Vision Pro with hip arthroscopy case at nationally recognized academic medical center

Stryker announced the successful completion of the first surgical procedure using its new SportSuite Vision application on Apple Vision Pro, performed at Duke Health. The software received FDA De Novo authorization in July, making it the first application cleared for intraoperative use with Apple's spatial computing headset. SportSuite Vision integrates arthroscopic video and medical imaging into the surgeon's field of view, aiming to streamline operating room workflows and reduce reliance on traditional monitors.

•2mo ago

Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering

Stryker signed a definitive agreement to acquire ZuriMED, the developer of the commercialized FiberLocker System for rotator cuff augmentation. The acquisition aims to strengthen Stryker’s shoulder portfolio and address a key clinical failure mode in the fast-growing sports medicine segment. The transaction remains subject to customary closing conditions, with both entities operating separately until the deal closes.

•2mo ago

Stryker and IAGE partner to advance clinical excellence in fluorescence-guided surgery in gynaecology in India

Stryker announced a strategic partnership with the Indian Association of Gynaecological Endoscopists (IAGE) to advance surgeon education in fluorescence-guided surgery (FGS) for gynaecology. The two-year collaboration, signed at the Pelvic Organ Prolapse Conference 2026, aims to deliver pan-India clinical educational initiatives. This partnership focuses on expanding access to high-quality training and fostering knowledge exchange to improve patient care standards.

•2mo ago

Stryker spotlights the joint replacement journey and the vital role of caregivers at the 2026 BMW Championship

Stryker will host a fan activation at the 2026 BMW Championship to highlight the joint replacement journey and the vital role of caregivers. Patient Tammy Accola-Newell and her husband Larry will walk inside the ropes as honorary observers to share her recovery experience using the BackInAction Knee and Mako SmartRobotics. The activation runs from August 18 to 23 at Bellerive Country Club, featuring educational resources and interactive activities for fans.

•2mo ago

Providence™ Medical Technology Appoints Lane Major as President & Chief Executive Officer

Providence Medical Technology appointed Lane Major as President and Chief Executive Officer, adding him to the Board of Directors to lead the company's next stage of growth. Major brings over 25 years of experience, most recently as CEO of Zavation Medical Products and previously as a co-founder of K2M, which was acquired by Stryker for $1.4 billion. The company noted that the hire comes during a period of strong commercial momentum for its CORUS tissue-sparing fusion platform and recently launched navigated solutions.

•2mo ago

Stryker declares an $0.88 per share quarterly dividend

Stryker's Board of Directors declared a quarterly dividend of $0.88 per share, payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026. The dividend represents a 4.8% increase versus the prior year, while remaining unchanged from the previous quarter. Stryker operates as a global leader in medical technologies, offering innovative products and services in MedSurg, Neurotechnology and Orthopaedics.

•2mo ago

Stryker reports second quarter 2026 operating results

Stryker posted Q2 net sales of $6.6 billion, up 9.4% year-over-year, with organic growth of 9.0% driven by increased unit volume across both MedSurg and Orthopaedics segments. Adjusted EPS rose 17.9% to $3.69, reflecting a 170 basis point expansion in adjusted operating margin to 27.4%, aided partially by a one-time $158 million reversal of 2025 tariffs. The company narrowed its full-year 2026 outlook, targeting organic sales growth of 8.3% to 9.3% and adjusted EPS between $14.95 and $15.10.

•3mo ago

Stryker expands Mako robotics portfolio with full market release of Mako RPS

Stryker announced the full U.S. commercial launch of Mako RPS, a handheld robotic system designed for total knee replacement procedures. The new system expands the Mako portfolio by combining robotic execution with traditional power tool workflows, and it is compatible with the Triathlon Total Knee System. Management reported strong customer response during the limited market release and expects the new technology to drive adoption in a broader segment of the orthopedic market.

•3mo ago

Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement

Stryker named professional golfer Shane Lowry as a sponsored brand ambassador for its Joint Replacement division to raise awareness about the patient and caregiver journey. Lowry will draw on his personal experience caring for his father, a joint replacement recipient, to highlight the critical role caregivers play in recovery and treatment decisions. The partnership includes a global campaign across media and social channels aimed at educating and empowering caregivers to support loved ones suffering from joint pain.

•4mo ago

Stryker Launches Pangea Plating System and Completes First Case in Europe

Stryker launched its Pangea Plating System in Europe, completing the first clinical case at St. George's University Hospital in London. The system, developed with input from 26 global surgeons, offers variable-angle plating and streamlined instrumentation for fracture fixation in upper and lower extremities. This launch expands Stryker’s trauma portfolio in the EMEA region, building on prior U.S. adoption and surgeon feedback.

•5mo ago

Stryker and Max Smart Hospital, Saket Partner to Advance Surgeon Training and Education in Robotic-Arm Assisted Joint Replacement

Stryker, a global leader in medical technologies, has partnered with Max Smart Super Speciality Hospital, Saket, to advance surgeon training and education in robotic-arm assisted joint replacement in India. The collaboration aims to develop long-term clinical expertise and improve access to technology-enabled treatment approaches, addressing the growing burden of arthritis and joint disorders in the country. Max Smart Super Speciality Hospital, Saket, will serve as a training and education center for orthopaedics, reflecting Stryker's commitment to enhancing patient outcomes and scaling robotics-assisted surgical capabilities in India.

•5mo ago

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Stryker completed the acquisition of Amplitude Vascular Systems, a privately held company focused on next-generation intravascular lithotripsy (IVL) technology for treating complex peripheral arterial disease. The deal adds AVS's CO₂-generated pressure wave technology to Stryker's peripheral vascular portfolio, enhancing its ability to address challenging arterial disease. CEO Kevin Lobo highlighted the acquisition as a significant milestone that leverages Stryker's scale to support physicians and improve patient outcomes.

•5mo ago

Stryker declares an $0.88 per share quarterly dividend

Stryker's Board of Directors declared a quarterly dividend of $0.88 per share, payable on July 31, 2026 to shareholders of record on June 30. The dividend represents a 4.8% increase compared to the prior year, although it remains unchanged from the previous quarter. The announcement reinforces the company's consistent capital return policy amidst its operations in MedSurg, Neurotechnology, and Orthopaedics.

•5mo ago

Stryker Launches Trident II Acetabular System in India for Advancing Hip Replacement Surgeries

Stryker announced the launch of the Trident II Acetabular System in India, introducing an advanced hip replacement solution designed for greater precision and stability. The system is compatible with Mako SmartRobotics and features proprietary technologies like Tritanium In-Growth Technology to support various patient anatomies. This launch builds on the Trident brand's 20-year legacy and addresses rising global demand for hip replacements driven by aging populations.

•6mo ago